Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression

胡椒碱通过变构拮抗剂作用调节TRPV2,从而抑制胶质母细胞瘤的进展

阅读:3
作者:João Conde,Ruth A Pumroy,Charlotte Baker,Tiago Rodrigues,Ana Guerreiro,Bárbara B Sousa,Marta C Marques,Bernardo P de Almeida,Sohyon Lee,Elvira P Leites,Daniel Picard ,Amrita Samanta,Sandra H Vaz,Florian Sieglitz,Maike Langini ,Marc Remke ,Rafael Roque,Tobias Weiss,Michael Weller,Yuhang Liu,Seungil Han,Francisco Corzana,Vanessa A Morais,Cláudia C Faria,Tânia Carvalho,Panagis Filippakopoulos,Berend Snijder,Nuno L Barbosa-Morais,Vera Y Moiseenkova-Bell,Gonçalo J L Bernardes

Abstract

The use of computational tools to identify biological targets of natural products with anticancer properties and unknown modes of action is gaining momentum. We employed self-organizing maps to deconvolute the phenotypic effects of piperlongumine (PL) and establish a link to modulation of the human transient receptor potential vanilloid 2 (hTRPV2) channel. The structure of the PL-bound full-length rat TRPV2 channel was determined by cryo-EM. PL binds to a transient allosteric pocket responsible for a new mode of anticancer activity against glioblastoma (GBM) in which hTRPV2 is overexpressed. Calcium imaging experiments revealed the importance of Arg539 and Thr522 residues on the antagonistic effect of PL and calcium influx modulation of the TRPV2 channel. Downregulation of hTRPV2 reduces sensitivity to PL and decreases ROS production. Analysis of GBM patient samples associates hTRPV2 overexpression with tumor grade, disease progression, and poor prognosis. Extensive tumor abrogation and long term survival was achieved in two murine models of orthotopic GBM by formulating PL in an implantable scaffold/hydrogel for sustained local therapy. Furthermore, in primary tumor samples derived from GBM patients, we observed a selective reduction of malignant cells in response to PL ex vivo. Our results establish a broadly applicable strategy, leveraging data-motivated research hypotheses for the discovery of novel means tackling cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。